Loss of heterozygosity at the mannose 6-phosphate insulin-like growth factor 2 receptor gene correlates with poor differentiation in early breast carcinomas
1997

Loss of heterozygosity at the IGF2R gene and breast cancer

Sample size: 62 publication Evidence: moderate

Author Information

Author(s): SA Chappell, T Walsh, RA Walker, JA Shaw

Primary Institution: University of Leicester

Hypothesis

Is loss of heterozygosity at the IGF2R gene an early event in the aetiology of breast cancer?

Conclusion

Loss of heterozygosity at the IGF2R gene is associated with poor differentiation in early breast cancer.

Supporting Evidence

  • None of the 40 early invasive carcinomas showed any evidence of LOH.
  • 4 out of 18 informative DCIS cases showed clear evidence of LOH.
  • Three of the four DCIS cases with LOH were high nuclear-grade cases.

Takeaway

The study found that some early breast cancers lose a specific gene that helps control cell growth, which is linked to more aggressive cancer types.

Methodology

The study analyzed 40 invasive breast carcinomas and 22 cases of ductal carcinoma in situ for loss of heterozygosity at the IGF2R gene using PCR.

Limitations

The study could not perform sequence analysis on cases with LOH due to insufficient DNA.

Participant Demographics

Participants included women with early-stage breast cancer detected by mammography, with no strong family history of breast cancer.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication